Skip to main content
Log in

I tumori androgeno-secernenti nella donna: dal sospetto clinico alla diagnosi

Proposto da Paolo Moghetti

  • Published:
L’Endocrinologo Aims and scope

Riassunto

I tumori androgeno-secernenti sono neoplasie rare che causano virilizzazione nella donna. La rapida insorgenza e progressione della sintomatologia sono una peculiarità. Il sospetto clinico richiede la conferma biochimica attraverso il dosaggio di testosterone e DHEA-S e la localizzazione della neoplasia attraverso risonanza magnetica nucleare surrenalica o ecografia ovarica; qualora lo studio di imaging risulti negativo è opportuno eseguire il cateterismo venoso selettivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliografia

  1. Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA 2006 Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91:2–6.

    Article  PubMed  CAS  Google Scholar 

  2. Barnor Q, Kurzawinski TA, Conway S Androgen-secreting tumours. In: Hay I, Wass J eds. Clinical Endocrine Oncology. Blackwell Publishing, Ltd, 2009, 390–395.

  3. Olt G, Mortel R 1997 Hormone-producing tumors of the ovary. Endocrine-Related Cancer 4:447–457.

    Article  Google Scholar 

  4. Toscano V, Adamo MV, Boscherini B et al 1981 The hormone pattern in a case of arrhenoblastoma. Eur J Pediatr 136:203–206.

    Article  PubMed  CAS  Google Scholar 

  5. Allolio B, Hahner S, Weiman D, Fassnatch M 2004 Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 60:273–287.

    Article  Google Scholar 

  6. Roman S 2006 Adrenocortical carcinoma. Curr Opin Oncol 18:36–42.

    Article  PubMed  Google Scholar 

  7. Azziz R, Carmina E, Dewailly D et al 2009 The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456–488.

    Article  PubMed  Google Scholar 

  8. Waggoner W, Boots LR, Azziz R 1999 Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecol Endocrinol 13:394–400.

    Article  PubMed  CAS  Google Scholar 

  9. Kaltsas GA, Isidori AM, Kola BP et al 2003 The value of the low dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism. J Clin Endocrinol Metab 88:2634–2643.

    Article  PubMed  CAS  Google Scholar 

  10. Ehrmann DA, Rosenfield RL 1990 Clinical Review: an endocrinologic approach to the patient with hirsutism. J Clin Endocrinol Metab 71:1–4.

    Article  PubMed  CAS  Google Scholar 

  11. Pascale MM, Pugeat M, Roberts M et al 1994 Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Clin Endocrinol (Oxf) 41:571–576.

    Article  CAS  Google Scholar 

  12. Jenebaum F, Groussin L, Foehrenbach H 2004 F-Fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenal tumours. Preliminary report of 13 consecutive patients. Eur J Endocrinol 150:789–792.

    Article  Google Scholar 

  13. Dennedy MC, Smith D, O’Shea D, McKenna TJ 2010 Investigation of patients with atipical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma. Eur J Endocrinol 162:213–220.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincenzo Toscano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Motta, C., Proietti-Pannunzi, L. & Toscano, V. I tumori androgeno-secernenti nella donna: dal sospetto clinico alla diagnosi. L’Endocrinologo 14, 243–249 (2013). https://doi.org/10.1007/BF03346111

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346111

Navigation